Corbus Pharmaceuticals Holdings, Inc.

CRBP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$40-$45-$42-$46
Dep. & Amort.-$3$1$1$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$0$6$9
Change in WC-$6$4-$4-$16
Other Non-Cash$1$4$2$2
Operating Cash Flow-$42-$36-$38-$48
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$181-$34-$86-$87
Inv. Sales/Matur.$59$70$116$14
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$121$36$30-$73
Financing Activities
Debt Repay.-$15-$3-$1$0
Stock Issued$182$0$0$63
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$2
Financing Cash Flow$167-$3-$1$61
Forex Effect$0$0$0$0
Net Chg. in Cash$3-$3-$8-$61
Supplemental Information
Beg. Cash$14$17$26$86
End Cash$18$14$18$26
Free Cash Flow-$42-$36-$38-$48
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financial Statements & Key Stats | AlphaPilot